Zdrowie i gospodarka · 13/12/2017
FDA Announces Draft Guidance on Refusing to File New Drug and Biologics Applications
The FDA has released a draft guidance to clarify when it may refuse to file new drug and biologics applications, aiming to minimize the risk of such actions and ensure complete submissions.
Source: Federal Register — Food and Drug AdministrationOpen original release →